Literature DB >> 31451659

Excessive CD11c+Tbet+ B cells promote aberrant TFH differentiation and affinity-based germinal center selection in lupus.

Wenqian Zhang1,2,3, Huihui Zhang1,2,3, Shujun Liu1,2,3, Fucan Xia1,2,3, Zijian Kang4, Yan Zhang1,2,3, Yaoyang Liu4, Hui Xiao5, Lei Chen1,2,3, Chuanxin Huang1,2,3, Nan Shen6, Huji Xu4, Fubin Li7,2,3.   

Abstract

Excessive self-reactive and inadequate affinity-matured antigen-specific antibody responses have been reported to coexist in lupus, with elusive cellular and molecular mechanisms. Here, we report that the antigen-specific germinal center (GC) response-a process critical for antibody affinity maturation-is compromised in murine lupus models. Importantly, this defect can be triggered by excessive autoimmunity-relevant CD11c+Tbet+ age-associated B cells (ABCs). In B cell-intrinsic Ship-deficient (ShipΔB) lupus mice, excessive CD11c+Tbet+ ABCs induce deregulated follicular T-helper (TFH) cell differentiation through their potent antigen-presenting function and consequently compromise affinity-based GC selection. Excessive CD11c+Tbet+ ABCs and deregulated TFH cell are also present in other lupus models and patients. Further, over-activated Toll-like receptor signaling in Ship-deficient B cells is critical for CD11c+Tbet+ ABC differentiation, and blocking CD11c+Tbet+ ABC differentiation in ShipΔB mice by ablating MyD88 normalizes TFH cell differentiation and rescues antigen-specific GC responses, as well as prevents autoantibody production. Our study suggests that excessive CD11c+Tbet+ ABCs not only contribute significantly to autoantibody production but also compromise antigen-specific GC B-cell responses and antibody-affinity maturation, providing a cellular link between the coexisting autoantibodies and inadequate affinity-matured antigen-specific antibodies in lupus models and a potential target for treating lupus.

Entities:  

Keywords:  CD11c+T-bet+ B cells; MyD88; autoantibody; germinal center selection; lupus

Year:  2019        PMID: 31451659      PMCID: PMC6744857          DOI: 10.1073/pnas.1901340116

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  81 in total

1.  Junctional amino acids determine the maturation pathway of an antibody.

Authors:  K Furukawa; A Akasako-Furukawa; H Shirai; H Nakamura; T Azuma
Journal:  Immunity       Date:  1999-09       Impact factor: 31.745

2.  Fas is required for clonal selection in germinal centers and the subsequent establishment of the memory B cell repertoire.

Authors:  Y Takahashi; H Ohta; T Takemori
Journal:  Immunity       Date:  2001-02       Impact factor: 31.745

3.  Role of antigen receptor affinity in T cell-independent antibody responses in vivo.

Authors:  Tien-An Yang Shih; Mario Roederer; Michel C Nussenzweig
Journal:  Nat Immunol       Date:  2002-03-18       Impact factor: 25.606

4.  Widespread susceptibility among inbred mouse strains to the induction of lupus autoantibodies by pristane.

Authors:  M Satoh; H B Richards; V M Shaheen; H Yoshida; M Shaw; J O Naim; P H Wooley; W H Reeves
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

5.  LPS-induced upregulation of SHIP is essential for endotoxin tolerance.

Authors:  Laura M Sly; Michael J Rauh; Janet Kalesnikoff; Christine H Song; Gerald Krystal
Journal:  Immunity       Date:  2004-08       Impact factor: 31.745

6.  Control of B-cell responses by Toll-like receptors.

Authors:  Chandrashekhar Pasare; Ruslan Medzhitov
Journal:  Nature       Date:  2005-11-17       Impact factor: 49.962

7.  SHIP recruitment attenuates Fc gamma RIIB-induced B cell apoptosis.

Authors:  R N Pearse; T Kawabe; S Bolland; R Guinamard; T Kurosaki; J V Ravetch
Journal:  Immunity       Date:  1999-06       Impact factor: 31.745

8.  Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme.

Authors:  M Muramatsu; K Kinoshita; S Fagarasan; S Yamada; Y Shinkai; T Honjo
Journal:  Cell       Date:  2000-09-01       Impact factor: 41.582

9.  Src homology 2 domain-containing inositol-5-phosphatase 1 (SHIP1) negatively regulates TLR4-mediated LPS response primarily through a phosphatase activity- and PI-3K-independent mechanism.

Authors:  Huazhang An; Hongmei Xu; Minghui Zhang; Jun Zhou; Tao Feng; Cheng Qian; Runzi Qi; Xuetao Cao
Journal:  Blood       Date:  2005-02-08       Impact factor: 22.113

10.  Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2).

Authors:  P Revy; T Muto; Y Levy; F Geissmann; A Plebani; O Sanal; N Catalan; M Forveille; R Dufourcq-Labelouse; A Gennery; I Tezcan; F Ersoy; H Kayserili; A G Ugazio; N Brousse; M Muramatsu; L D Notarangelo; K Kinoshita; T Honjo; A Fischer; A Durandy
Journal:  Cell       Date:  2000-09-01       Impact factor: 41.582

View more
  22 in total

1.  Understanding the Heterogeneous Population of Age-Associated B Cells and Their Contributions to Autoimmunity and Immune Response to Pathogens.

Authors:  Olivia Kugler-Umana; Priyadharshini Devarajan; Susan L Swain
Journal:  Crit Rev Immunol       Date:  2020       Impact factor: 2.214

2.  Interleukin-13 Receptor α1-Mediated Signaling Regulates Age-Associated/Autoimmune B Cell Expansion and Lupus Pathogenesis.

Authors:  Zhu Chen; Danny Flores Castro; Sanjay Gupta; Swati Phalke; Michela Manni; Juan Rivera-Correa; Rolf Jessberger; Habib Zaghouani; Eugenia Giannopoulou; Tania Pannellini; Alessandra B Pernis
Journal:  Arthritis Rheumatol       Date:  2022-08-22       Impact factor: 15.483

3.  Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19.

Authors:  Matthew C Woodruff; Richard P Ramonell; Doan C Nguyen; Kevin S Cashman; Ankur Singh Saini; Natalie S Haddad; Ariel M Ley; Shuya Kyu; J Christina Howell; Tugba Ozturk; Saeyun Lee; Naveenchandra Suryadevara; James Brett Case; Regina Bugrovsky; Weirong Chen; Jacob Estrada; Andrea Morrison-Porter; Andrew Derrico; Fabliha A Anam; Monika Sharma; Henry M Wu; Sang N Le; Scott A Jenks; Christopher M Tipton; Bashar Staitieh; John L Daiss; Eliver Ghosn; Michael S Diamond; Robert H Carnahan; James E Crowe; William T Hu; F Eun-Hyung Lee; Ignacio Sanz
Journal:  Nat Immunol       Date:  2020-10-07       Impact factor: 25.606

4.  Host Genetics But Not Commensal Microbiota Determines the Initial Development of Systemic Autoimmune Disease in BXD2 Mice.

Authors:  Huixian Hong; Fatima Alduraibi; David Ponder; Wayne L Duck; Casey D Morrow; Jeremy B Foote; Trenton R Schoeb; Huma Fatima; Charles O Elson; Hui-Chen Hsu; John D Mountz
Journal:  Arthritis Rheumatol       Date:  2022-02-10       Impact factor: 10.995

5.  Determinants of B-Cell Compartment Hyperactivation in European Adolescents Living With Perinatally Acquired HIV-1 After Over 10 Years of Suppressive Therapy.

Authors:  Alessandra Ruggiero; Giuseppe Rubens Pascucci; Nicola Cotugno; Sara Domínguez-Rodríguez; Stefano Rinaldi; Alfredo Tagarro; Pablo Rojo; Caroline Foster; Alasdair Bamford; Anita De Rossi; Eleni Nastouli; Nigel Klein; Elena Morrocchi; Benoit Fatou; Kinga K Smolen; Al Ozonoff; Michela Di Pastena; Katherine Luzuriaga; Hanno Steen; Carlo Giaquinto; Philip Goulder; Paolo Rossi; Ofer Levy; Savita Pahwa; Paolo Palma
Journal:  Front Immunol       Date:  2022-03-31       Impact factor: 7.561

6.  In vivo Screen Identifies Zdhhc2 as a Critical Regulator of Germinal Center B Cell Differentiation.

Authors:  Rongqing Zhao; Huihui Zhang; Yan Zhang; Dan Li; Chuanxin Huang; Fubin Li
Journal:  Front Immunol       Date:  2020-06-10       Impact factor: 7.561

Review 7.  Update on the Genetics of Systemic Lupus Erythematosus: Genome-Wide Association Studies and Beyond.

Authors:  Young-Chang Kwon; Sehwan Chun; Kwangwoo Kim; Anselm Mak
Journal:  Cells       Date:  2019-09-30       Impact factor: 6.600

8.  Sustained low-dose interleukin-2 therapy alleviates pathogenic humoral immunity via elevating the Tfr/Tfh ratio in lupus.

Authors:  Kaili Liang; Jing He; Yunbo Wei; Qunxiong Zeng; Dongcheng Gong; Jiahuan Qin; Huihua Ding; Zhian Chen; Ping Zhou; Peng Niu; Qian Chen; Chenguang Ding; Liangjing Lu; Xiao-Xiang Chen; Zhanguo Li; Nan Shen; Di Yu; Jun Deng
Journal:  Clin Transl Immunology       Date:  2021-06-01

Review 9.  Peripheral B Cell Subsets in Autoimmune Diseases: Clinical Implications and Effects of B Cell-Targeted Therapies.

Authors:  Wanlin Jin; Zhaohui Luo; Huan Yang
Journal:  J Immunol Res       Date:  2020-03-23       Impact factor: 4.818

Review 10.  Therapeutic implications of the anergic/postactivated status of B cells in systemic lupus erythematosus.

Authors:  Thomas Dörner; Franziska Szelinski; Andreia C Lino; Peter E Lipsky
Journal:  RMD Open       Date:  2020-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.